Dive Brief:
- UnitedHealth outperformed Wall Street’s expectations in the second quarter and hiked its 2026 earnings outlook far higher than analysts predicted, suggesting the healthcare behemoth may have gotten a firm handle on soaring medical costs.
- UnitedHealth’s second quarter revenue of $112 billion was essentially unchanged year over year. But net income spiked almost 62% to $5.5 billion, thanks to profit recovery in both its insurance plans and care delivery unit Optum Health.
- The Minnesota-based company revised its 2026 outlook for adjusted earnings per share to $19.50 to $20, up from more than $18.25 per share previously. Analysts had expected the company to boost its outlook, but not by that much. UnitedHealth’s stock rose almost 9% following the results, with burgeoning investor optimism also boosting shares in other managed care companies.
Dive Insight:
Investors expected health insurers to outperform in the second quarter, after signs margin recovery strategies were beginning to bear fruit after a difficult few years.
Americans’ medical utilization and the cost of those services soared coming out of the coronavirus pandemic, and premiums haven’t been enough to cover the trend. The mismatch has been particularly acute in government programs like Medicare Advantage and Medicaid where insurers have less control over reimbursement.
UnitedHealth has been attempting to get back to solid financial ground after medical costs slammed its bottom line in 2024 and 2025. The company made notable progress in the first quarter, outperforming analysts’ expectations and boosting its 2026 outlook — two indicators of momentum that UnitedHealth has now repeated.
UnitedHealth “cleared the high bar set by investors,” J.P. Morgan analyst Lisa Gill wrote in a research note.
UnitedHealthcare, UnitedHealth’s insurance division and the largest private insurer in the U.S., reported earnings of $3.9 billion, up 86% year over year, after the insurer hiked premiums, exited underperforming markets and trimmed benefits for 2026.
The insurer’s revenue of $86 billion was flat year over year but above analyst expectations, as higher revenue from employer-sponsored insurance plans was cancelled out by membership losses in Medicare and Medicaid.
UnitedHealthcare’s membership fell by 525,000 individuals compared to the first quarter, to 48.5 million people.
The drop was primarily fueled by Medicare Advantage. UnitedHealthcare ended the quarter with 965,000 fewer seniors in the privatized Medicare program than in the first. However, member retention was actually better than the company had expected, UnitedHealthcare CEO Tim Noel said on a call with investors. UnitedHealth continues to expect it will lose up to 1.1 million MA members this year.
Costs in MA, which have proved the biggest wrinkle in UnitedHealthcare’s efforts to recover margins, remain elevated but were lower in the second quarter than UnitedHealth had planned, executives said. UnitedHealthcare expects its MA business to operate at positive margins this year.
UnitedHealthcare’s Medicaid business should operate at a loss, as states’ payment rates continue to lag spending, according to Noel. However, UnitedHealth said it’s beginning to see the gap between payment rates and member acuity close — and utilization trends are in line with what the company had planned, executives added.
The outlier was UnitedHealthcare’s commercial business. Spending in employer-sponsored plans remains doggedly above expectations, executives told investors.
UnitedHealth primarily blamed the arbitration process created by a law to resolve out-of-network disputes between payers and providers — a major gripe for insurers, which argue a small group of providers are filing a mountain of disputes to get inflated payouts.
“The ineffective IDR process that’s associated with the No Surprises Act is being exploited by select providers in select geographies,” said Dan Kueter, who leads UnitedHealthcare’s employer business.
More aggressive provider billing practices and inflated spending on specialty drugs, including GLP-1s, is also making it harder for UnitedHealth to recover its commercial margins.
“Simply put, we’re not yielding the full margin expansion for which we planned in 2026,” Kueter said.
Results for UnitedHealth’s other major reporting division, health services business Optum, were “exceptional,” according to Leerink analyst Whit Mayo.
The standout was Optum Health, UnitedHealth’s care delivery arm and the largest physician enterprise in the U.S. with roughly 90,000 owned or affiliated doctors. Along with providing medical care to consumers, Optum Health also enters into value-based contracts with insurers to care for their members in MA — a business that’s seen sinking profits in recent years from higher spending on seniors’ care.
In a bid to recoup profits, Optum Health cut certain providers from its network and slashed its risk-based membership, including by dropping unprofitable contracts. Those strategies led to a sizable outperformance in the first and the second quarter, with Optum Health boosting its second quarter earnings to $1.2 billion, more than double analysts’ consensus expectations.
The earnings recovery has come at a cost to its membership. Optum Health has lost 700,000 value-based patients year over year.
Still, that tradeoff has fueled distinct earnings growth for Optum. The division reported operating income of $4 billion, up 29% year over year, on revenue of $65.7 billion, down 2%. Earnings also improved for technology unit Optum Insight and pharmacy benefits manager Optum Rx.
“[Management] has emphasized margin improvement, and 2Q progress was impressive,” Jefferies analyst David Windley wrote in a Thursday note.
